论文信息 - Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance - 字舞流文

Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance

Dorte B. Bekker-Jensen | Kristina B. Emdal | J. Olsen | J. Saez-Rodriguez | P. Blume-Jensen | Kristina Masson | L. Rönnstrand | J. U. Kazi | R. Itzykson | A. Puissant | H. Nilsson | Caroline Wigerup | Nicolàs Palacio-Escat | A. Eguchi | Helén Nilsson | Julhash U. Kazi | K. B. Emdal